Back to Search
MARK ZALUPSKI, MD
MD
Medical Oncology Physician
NPI: 1528144490IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
4301048736(MI)
Education
WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE
Class of 1982
Research & Publications (20)
Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.
PMID 14770440·Cancer·2004
3-trial
Gemcitabine-based combination chemotherapy followed by radiation with capecitabine as adjuvant therapy for resected pancreas cancer.
PMID 19409732·Int J Radiat Oncol Biol Phys·2009
8-other
Radiotherapy for pancreatic neuroendocrine tumors.
PMID 19327905·Int J Radiat Oncol Biol Phys·2009
8-other
A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer.
PMID 18712502·Invest New Drugs·2009
3-trial
Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer.
PMID 17429629·Cancer Chemother Pharmacol·2008
3-trial
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.
PMID 18281668·J Clin Oncol·2008
3-trial
Phase I study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancer.
PMID 17925553·J Clin Oncol·2007
3-trial
A phase I study of gemcitabine and uracil-ftorfar (UFT)/leucovorin.
PMID 17414457·Am J Clin Oncol·2007
3-trial
Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma.
PMID 17464949·Cancer·2007
3-trial
Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site.
PMID 17594717·Cancer·2007
3-trial
Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer.
PMID 17379445·Int J Radiat Oncol Biol Phys·2007
3-trial
A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancer.
PMID 17762432·Am J Clin Oncol·2007
3-trial
A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers.
PMID 17364234·Invest New Drugs·2007
3-trial
External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.
PMID 17011452·Int J Radiat Oncol Biol Phys·2006
8-other
A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma.
PMID 16418882·Ann Surg Oncol·2006
3-trial
A phase II study of chloroquinoxaline sulfonamide (CQS) in patients with metastatic colorectal carcinoma (MCRC).
PMID 16446986·Invest New Drugs·2006
3-trial
Phase II trial of gemcitabine as first line chemotherapy in patients with metastatic or unresectable soft tissue sarcoma.
PMID 16462504·Am J Clin Oncol·2006
3-trial
A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer.
PMID 16034525·Invest New Drugs·2005
3-trial
Assessment of infusional 5-fluorouracil schedule and dose intensity: a Southwest Oncology Group and Eastern Cooperative Oncology Group study.
PMID 16098253·Clin Colorectal Cancer·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 E MEDICAL CENTER DR
ANN ARBOR, MI 48109 - Phone
- (734) 936-4000
Quick Facts
- NPI
- 1528144490
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 44
- Publications
- 20
Are you this provider?
Claim Your Profile